Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D271-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-215 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-113 |
filingDate |
1978-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2adb7b4a3faa3c1423c2042e310c0df2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c50578d0035c58e4f3c8b1cf08de0195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1666f9aa466f12d0c2076ed3936a32a2 |
publicationDate |
1979-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-7900166-A1 |
titleOfInvention |
Cyanocarboxamidines and quinazoline process |
abstract |
Novel cyanocarboxamidines and a method for their preparation are disclosed. The use of these new cyanocarboxamidines as intermediates in the one step synthesis of antihypertensive 4-amino-2-(4-substituted-piperazine-1-yl)-quinozolines is also disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0022481-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4578389-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-900100294-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0146642-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4647684-A |
priorityDate |
1977-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |